Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human plasma-like medium improves T lymphocyte activation

ABSTRACT: Human plasma-like medium improves T lymphocyte activation

PROVIDER: PRJNA560687 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR9993430_1.fastq.gz	Fastqsanger.gz
	SRR9993430_2.fastq.gz	Fastqsanger.gz
	SRR9993431_1.fastq.gz	Fastqsanger.gz
	SRR9993431_2.fastq.gz	Fastqsanger.gz
	SRR9993432_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 24

Similar Datasets

Human plasma-like medium improves T lymphocyte activation

Project description:T lymphocytes are critical effectors of the immune system and the ability to study their behavior in synthetic media in vitro has facilitated major discoveries in their development, function, and fate. Recently, it has been shown that the constituents in human plasma differ markedly from commonly used synthetic media and these differences have important effects on cell physiology. We therefore compared T lymphocyte activation in human plasma-like medium (HPLM) to RPMI conventional medium both with and without serum. We found that HPLM and RPMI induced vastly different transcriptional programs, especially for transcripts encoding proteins involved in activation, proliferation and metabolism, in human peripheral blood T cells after T cell receptor (TCR) stimulation. We also found that in dialyzed fetal bovine serum (dFBS), HPLM supports a stronger response to TCR engagement compared to RPMI. In reconstruction experiments, we demonstrated that this activation difference is due to RPMI being hypocalcemic relative to the in vivo milieu and that addition of calcium chloride to RPMI can improve human T lymphocyte activation. Thus, we conclude that investigators should be cognizant of differences between commonly used media formulations and the in vivo environment since this could profoundly affect their experimental results and that physiologic media is a valuable new way to study immune cells in culture

2020-01-21 | GSE135936 | GEO

Human Plasma-like Medium Improves T Lymphocyte Activation.

Project description:T lymphocytes are critical for effective immunity, and the ability to study their behavior in vitro can facilitate major insights into their development, function, and fate. However, the composition of human plasma differs from conventional media, and we hypothesized that such differences could impact immune cell physiology. Here, we showed that relative to the medium typically used to culture lymphocytes (RPMI), a physiologic medium (human plasma-like medium; HPLM) induced markedly different transcriptional responses in human primary T cells and in addition, improved their activation upon antigen stimulation. We found that this medium-dependent effect on T cell activation is linked to Ca2+, which is six-fold higher in HPLM than in RPMI. Thus, a medium that more closely resembles human plasma has striking effects on T cell biology, further demonstrates that medium composition can profoundly affect experimental results, and broadly suggests that physiologic media may offer a valuable way to study cultured immune cells.

| S-EPMC6941860 | biostudies-literature

Effects of Human Plasma-Like Medium on hPSC-derived cardiomyocytes in vitro

Project description:Maturing hPSC-CMs in vitro is critical for advancing drug discovery and cardiotoxicity screening. However, widely used basal medium such as RPMI contain non-physiological compositions that limit their relevance to human cardiac physiology. In this study we introduced Human Plasma-Like Medium (HPLM) as a better basal medium supplemented with B27, a physiologically tailored alternative designed to systematically replicate the salt concentrations and polar metabolite profiles of adult human plasma. Starting with Day16 hPSC-CMs, we cultured cells for two weeks in HPLM/B27 or control media (standard and low-glucose [5 mM] RPMI/B27) and assessed maturation outcomes at Day30. Compared to standard and low-glucose RPMI/B27, HPLM/B27 significantly enhanced hPSC-CM maturity across transcriptomic, structural, functional, and metabolic aspects. These improvements included accomplished myosin heavy chain isoform switching (MYH6 to MYH7), accelerated ventricular-specific myosin light chain isoform switching (MLC2a to MLC2v), elongated sarcomeres (~2.07 µm), enhanced calcium transient kinetics, and coordinated activation of oxidative and glycolytic metabolism. Collectively, these findings establish HPLM as a better basal medium than low glucose RPMI for driving cardiomyocyte maturation in vitro.

2026-04-02 | GSE294004 | GEO

Systemic inflammation and lymphocyte activation precede rheumatoid arthritis

Project description:Systemic inflammation and lymphocyte activation precede rheumatoid arthritis

| PRJNA1227600 | ENA

Systemic inflammation and lymphocyte activation precede rheumatoid arthritis

Project description:Systemic inflammation and lymphocyte activation precede rheumatoid arthritis

| PRJNA1227601 | ENA

Comparison of the lymphocyte before and after the activation.

Project description:Immunotherapy using activated lymphocytes has recently been developed, but there is not yet the biomarker which can predict curative effect. In our recent study, we found that random migration is significantly increased in activated lymphocyte. Furthermore, it is suggested that random migration may affect cytotoxicity. Therefore we considered that migration of lymphocyte may become the effect prediction biomarker of Immunotherapy. And then we analyzed the gene which fluctuated by lymphocyte activation to search the molecules which positive regulate migration of lymphocyte.

2019-08-31 | GSE86293 | GEO

Plasma proteomics improves thrombosis prediction in cancer and implicates a targetable IL-17-driven endothelial activation pathway

Project description:Plasma proteomics improves thrombosis prediction in cancer and implicates a targetable IL-17-driven endothelial activation pathway

| PRJNA1330615 | ENA

An α-specific PI3K inhibitor improves chemotherapy efficacy by inhibiting hepatic stellate cell activation in liver cancer

Project description:The poor response to current systemic treatments in liver cancer has been associated with the activation of cancer-associated fibroblasts (CAFs). Herein, we aimed to investigate the effects of chemotherapy on hepatic stellate cells (HSCs), the main origin of CAFs in liver cancer. In vitro experiments demonstrated that cisplatin activated HSCs through a paracrine effect from HCC tumour cells while the mechanism remains unknown. RNA sequencing of human primary HSCs incubated in untreated or cisplatin-pretreated Huh7 conditioned medium revealed a PI3K signaling pathwayof HSC activation. Further analyses showed that PI3K pathway, especially PI3K p110a is crucial for HSC activation and by targeting PI3K p110a, HSC activation induced by cisplatin can be completely inhibited and improves cisplatin therapeutic efficacy.

2026-01-12 | GSE315789 | GEO

Effects of Human Plasma-Like Medium on hPSC-derived cardiomyocytes in vitro

Project description:Effects of Human Plasma-Like Medium on hPSC-derived cardiomyocytes in vitro

| PRJNA1247583 | ENA

Pharmacokinetics and Metabolic Activation of Capecitabine

Project description:The objective of this pharmacokinetic study is to exclude a possible influence of CETUX on the plasma disposition and metabolic activation of Capecitabine (CCB) and when this regimen is given combined with Oxaliplatin (OxPt).

| 2123891 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data